| For: | Guo XY, Sun F, Chen JN, Wang YQ, Pan Q, Fan JG. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World J Gastroenterol 2018; 24(3): 323-337 [PMID: 29391755 DOI: 10.3748/wjg.v24.i3.323] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i3/323.htm |
| Number | Citing Articles |
| 1 |
Xueyuan Sun, Kaiyuan Deng, Yunhui Zang, Zhiyong Zhang, Boxin Zhao, Jingyao Fan, Lijuan Huang. Exploring the regulatory roles of circular RNAs in the pathogenesis of atherosclerosis. Vascular Pharmacology 2021; 141 doi: 10.1016/j.vph.2021.106898
|
| 2 |
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2020; 14(8) doi: 10.1080/17474124.2020.1780915
|
| 3 |
Yishan Ge, Wenwu Liu, Wei Yin, Xuebin Wang, Jie Wang, Xiaoqing Zhu, Shengkai Xu. Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells. Bioengineered 2021; 12(2) doi: 10.1080/21655979.2021.1989260
|
| 4 |
Yiyi Zhu, Weiwei Gui, Xihua Lin, Hong Li. Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1. Experimental Cell Research 2020; 387(2) doi: 10.1016/j.yexcr.2019.111753
|
| 5 |
Farooq Riaz, Dongmin Li. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Current Gene Therapy 2019; 19(5) doi: 10.2174/1566523219666191107113046
|
| 6 |
Sanyang Chen, Hongbo Fang, Jie Li, Jihua Shi, Jiakai Zhang, Peihao Wen, Zhihui Wang, Han Yang, Shengli Cao, Huapeng Zhang, Hongwei Tang, Wenzhi Guo, Shuijun Zhang. Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver Transplantation. BioMed Research International 2019; 2019 doi: 10.1155/2019/5604843
|
| 7 |
Zheng-hua Liu, Shi-ze Yang, Wen-ya Li, Si-yuan Dong, Si-yu Zhou, Shun Xu. circRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 gene. Aging 2021; 13(8) doi: 10.18632/aging.103071
|
| 8 |
Jesus Rivera-Aguirre, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Metabolic-associated Fatty Liver Disease Regulation through Nutri Epigenetic
Methylation. Mini-Reviews in Medicinal Chemistry 2023; 23(17) doi: 10.2174/1389557523666230130093512
|
| 9 |
Qingmin Zeng, Chang-Hai Liu, Javier Ampuero, Dongbo Wu, Wei Jiang, Lingyun Zhou, Hong Li, Lang Bai, Manuel Romero-Gómez, Hong Tang. Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance. RNA Biology 2024; 21(1) doi: 10.1080/15476286.2023.2290769
|
| 10 |
Ju Zhou, Wu Li, Xiaowei Chi, Dingchun Li, Chunxia Yang, Zhiwen Duan. Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress. Endocrine Journal 2025; 72(1) doi: 10.1507/endocrj.EJ24-0008
|
| 11 |
Mengyao Zheng, Dongyun Cun, Haiyu He, Xuancheng Xie, Hongtao Lei, Wen Fu, Wenlin Tai, Jinhui Yang. Expression profile and N6-methyadenosine modification of circular RNA analysis in MAFLD. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03722-4
|
| 12 |
Yuanyong Wang, Jin Zhang, Yuchen Yang, Zhuofeng Liu, Sijia Sun, Rui Li, Hui Zhu, Tian Li, Jin Zheng, Jie Li, Litian Ma. Circular RNAs in human diseases. MedComm 2024; 5(9) doi: 10.1002/mco2.699
|
| 13 |
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
|
| 14 |
Xiaoni Huang, Yuwen Zhao, Huijiao Zhou, Yongqiang Li. Circular RNAs in atherosclerosis. Clinica Chimica Acta 2022; 531 doi: 10.1016/j.cca.2022.03.016
|
| 15 |
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
|
| 16 |
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147716
|
| 17 |
Ruixian Huang, Xiaoyan Duan, Jangao Fan, Guangming Li, Baocan Wang. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. BioMed Research International 2019; 2019 doi: 10.1155/2019/8690592
|
| 18 |
Xi Jin, Jianguo Gao, Ruoheng Zheng, Mosang Yu, Yue Ren, Tianlian Yan, Yue Huang, Youming Li. Antagonizing circRNA_002581–miR-122–CPEB1 axis alleviates NASH through restoring PTEN–AMPK–mTOR pathway regulated autophagy. Cell Death & Disease 2020; 11(2) doi: 10.1038/s41419-020-2293-7
|
| 19 |
Marwa Abdelgwad, Reem Zakaria, Samar Marzouk, Dina Sabry, Rasha Ahmed, Hedy Ayman Badary, Mai Samir. The Emerging Role of Circular RNA Homeodomain Interacting Protein Kinase 3 and Circular RNA 0046367 through Wnt/Beta-Catenin Pathway on the Pathogenesis of Nonalcoholic Steatohepatitis in Egyptian Patients. Reports of Biochemistry and Molecular Biology 2023; 11(4) doi: 10.52547/rbmb.11.4.614
|
| 20 |
Jianguo Wu, Laura E. Nagy, Suthat Liangpunsakul, Li Wang. Non-coding RNA crosstalk with nuclear receptors in liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021; 1867(5) doi: 10.1016/j.bbadis.2021.166083
|
| 21 |
Cheng Wen, Bowei Li, Lei Nie, Ling Mao, Yuanpeng Xia. Emerging Roles of Extracellular Vesicle-Delivered Circular RNAs in Atherosclerosis. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.804247
|
| 22 |
Jiaming Zhou, Jiaxuan Liu, Dikun Wu, Junjie Ding, Binbin Li, Hongyu Yu. hsa_circ_0001377 promotes hepatic fibrosis by sponging let-7a-5p and targeting TGFBR1, Smad2, and Col1a2. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1882205
|
| 23 |
Stephen Hong, Darren Gordon, David E. Stec, Terry D. Hinds. Nuclear Receptors. 2021; doi: 10.1007/978-3-030-78315-0_17
|
| 24 |
Wenjun Yang, Jinduo Zhao, Ye Zhao, Wenfeng Li, Liang Zhao, Yi Ren, Rongying Ou, Yunsheng Xu. Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signaling. Aging 2020; 12(23) doi: 10.18632/aging.104081
|
| 25 |
Shreyoshi Guha, Selvam Sesili, Ishfaq Hassan Mir, Chinnasamy Thirunavukkarasu. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver disease. Cell Biochemistry and Function 2023; 41(1) doi: 10.1002/cbf.3763
|
| 26 |
Cong Liu, Xilin Liu, Hong Li, Zhichen Kang. Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1173904
|
| 27 |
Yueh Chien, Ping-Hsing Tsai, Ying-Hsiu Lai, Kai-Hsi Lu, Chao-Yu Liu, Heng-Fu Lin, Chi-Shuan Huang, Wai-Wah Wu, Chien-Ying Wang. CircularRNA as novel biomarkers in liver diseases. Journal of the Chinese Medical Association 2020; 83(1) doi: 10.1097/JCMA.0000000000000230
|
| 28 |
Xianhui Zeng, Xianglei Yuan, Qiuyu Cai, Chengwei Tang, Jinhang Gao. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021; 10(8) doi: 10.3390/cells10081945
|
| 29 |
Baoyi Zhu, Zhanfang Kang, Sihua Zhu, Yuying Zhang, Xiangmao Lai, Lilin Zhou, Hai Huang, Xiaofeng Gao, Chonghe Jiang, Jianwen Zeng. Multi-Omics Characterization of Circular RNA-Encoded Novel Proteins Associated With Bladder Outlet Obstruction. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.772534
|
| 30 |
Yuanyuan Zhang, Zhichen Tian, Haibo Ye, Xiaomei Sun, Huiming Zhang, Yujia Sun, Yongjiang Mao, Zhangping Yang, Mingxun Li. Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01062-w
|
| 31 |
Chen Chen, Xing Zhang, Yuan Deng, Qingming Cui, Ji Zhu, Huibo Ren, Yingying Liu, Xionggui Hu, Jianbo Zuo, Yinglin Peng. Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid‐related diseases. The FEBS Journal 2021; 288(12) doi: 10.1111/febs.15525
|
| 32 |
Li-Da Chen, Jie-Feng Huang, Xue-Jun Lin, Ya-Ping Huang, Qiao-Zhen Xu, Gong-Ping Chen, Qi-Chang Lin. Expression profiling and functional analysis of circular RNAs in vitro model of intermittent hypoxia-induced liver injury. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.972407
|
| 33 |
Tianhui Wang, Wen Pan, Jun Hu, Zhongrong Zhang, Guoping Li, Yajun Liang. Circular RNAs. Advances in Experimental Medicine and Biology 2018; 1087 doi: 10.1007/978-981-13-1426-1_22
|
| 34 |
Renzhi Yao, Haifan Zou, Weijia Liao. Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00332
|
| 35 |
Guangli Yu, Zhou Yang, Tianhong Peng, Yuncheng Lv. Circular RNAs: Rising stars in lipid metabolism and lipid disorders. Journal of Cellular Physiology 2021; 236(7) doi: 10.1002/jcp.30200
|
| 36 |
Daniela Bernal-Vázquez, Ignacio Bolaños-Fernández, Gabriel O. Salcedo-Rivas, Marcela Figueroa-Ramírez, Asim K. Duttaroy, Sujay Paul. Circular RNAs in obesity and related metabolic disorders: mechanistic insights and therapeutic perspectives. Frontiers in Genetics 2026; 17 doi: 10.3389/fgene.2026.1763596
|
| 37 |
Luisa Sophie Rajcsanyi, Triinu Peters, Anke Hinney. Advances in Circular RNAs. Advances in Experimental Medicine and Biology 2025; 1485 doi: 10.1007/978-981-96-9428-0_20
|
| 38 |
Mohamed Zaiou. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Advances in Experimental Medicine and Biology 2019; 1134 doi: 10.1007/978-3-030-12668-1_10
|
| 39 |
Bo Liu, Weili Liu, Hongbo Li, Nailiang Zhai, Changjun Lv, Xiaodong Song, Shuanying Yang. circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway. Cellular and Molecular Life Sciences 2025; 82(1) doi: 10.1007/s00018-025-05613-z
|
| 40 |
Yang En‐Xi Chen, Amir Amir Samih Sadek, Fang Li, Guo‐Zheng Zhang, Ning‐Lin Wu, Xiao‐Dong Sun, Mohamed El‐Kassas, Ahmed Ihab Abdelaziz, Yuan‐Yuan Zhang, Injie Omar Fawzy. Sexual Dimorphism in Metabolic Dysfunction‐Associated Steatotic Liver Disease: The Emerging Role of Non‐Coding RNAs. Comprehensive Physiology 2026; 16(3) doi: 10.1002/cph4.70156
|
| 41 |
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 2023; 251 doi: 10.1016/j.prp.2023.154809
|
| 42 |
Yongzhi Zeng, Zhi Zheng, Fengtao Liu, Guanghui Yi. Circular RNAs in metabolism and metabolic disorders. Obesity Reviews 2021; 22(7) doi: 10.1111/obr.13220
|
| 43 |
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
|
| 44 |
Azadeh Taherpour, Safieh Ebrahimi, Farshad Mirzavi. A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome. BioFactors 2025; 51(6) doi: 10.1002/biof.70053
|
| 45 |
Zhuo Huang, Qinyan Yao, Shuang Ma, Jinjie Zhou, Xiaoxuan Wang, Qingguo Meng, Yaxin Liu, Zihan Yu, Xin Chen. The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1504395
|
| 46 |
Nan Sheng, Yitao Pan, Yong Guo, Yan Sun, Jiayin Dai. Hepatotoxic Effects of Hexafluoropropylene Oxide Trimer Acid (HFPO-TA), A Novel Perfluorooctanoic Acid (PFOA) Alternative, on Mice. Environmental Science & Technology 2018; 52(14) doi: 10.1021/acs.est.8b01714
|
| 47 |
Claudia Theys, Dorien Lauwers, Claudina Perez-Novo, Wim Vanden Berghe. PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?. Biomedicines 2022; 10(12) doi: 10.3390/biomedicines10123041
|
| 48 |
Hongkun Joy Lu, Huiping Zhou. Circular RNAs in metabolic liver diseases: Biomarkers, mechanisms, and therapeutic perspectives. Metabolism and Diseases 2026; 1(2) doi: 10.1016/j.metdis.2026.100022
|
| 49 |
Xinlu Yuan, Jianjun Diao, Anqing Du, Song Wen, Ligang Zhou, Yangbin Pan. Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02637-w
|
| 50 |
. 2021; doi: 10.70675/ad7bd189z46afz42a0za237z014930bed948
|
| 51 |
Carlos Jose Pirola, Silvia Sookoian. Epigenetics factors in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2022; 16(6) doi: 10.1080/17474124.2020.1765772
|
| 52 |
Biao Li, Jinzeng Yang, Jun He, Yan Gong, Yu Xiao, Qinghua Zeng, Kang Xu, Yehui Duan, Jianhua He, Haiming Ma. Spatiotemporal Regulation and Functional Analysis of Circular RNAs in Skeletal Muscle and Subcutaneous Fat during Pig Growth. Biology 2021; 10(9) doi: 10.3390/biology10090841
|
| 53 |
Jian Li, Jing Qi, Yishu Tang, Huaizheng Liu, Kefu Zhou, Zheren Dai, Lehong Yuan, Chuanzheng Sun. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01108-8
|
| 54 |
Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi, Stéphane Mandard. Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets. PPAR Research 2022; 2022 doi: 10.1155/2022/6161694
|
| 55 |
Zhaoxiong Lei, Huiguang Wu, Yan Xiong, Dawei Wei, Xingping Wang, Zhuoma Luoreng, Xiaoyan Cai, Yun Ma. ncRNAs regulate bovine adipose tissue deposition. Molecular and Cellular Biochemistry 2021; 476(7) doi: 10.1007/s11010-021-04132-2
|
| 56 |
Qin Pan, Jian-Gao Fan, Yusuf Yilmaz. Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023; 27(2) doi: 10.1016/j.cld.2023.01.013
|
| 57 |
Fanglin Wang, Xiang Li, Zhiyuan Li, Shoushuai Wang, Jun Fan. Functions of Circular RNAs in Regulating Adipogenesis of Mesenchymal Stem Cells. Stem Cells International 2020; 2020 doi: 10.1155/2020/3763069
|
| 58 |
Yanru Zhang, Ruike Ding, Liangshuo Hu, Enqi Liu, Pengxiang Qu. Epigenetics in metabolic dysfunction-associated steatohepatitis. Cellular Signalling 2025; 130 doi: 10.1016/j.cellsig.2025.111684
|
| 59 |
Samar A. Zailaie, Basmah B. Khoja, Jumana J. Siddiqui, Mohammad H. Mawardi, Emily Heaphy, Amjad Aljagthmi, Consolato M. Sergi. Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease. Non-Coding RNA 2024; 10(1) doi: 10.3390/ncrna10010010
|
| 60 |
Mohamed Zaiou. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. Cells 2023; 12(8) doi: 10.3390/cells12081205
|
| 61 |
Anqi Li, Rui Wang, Yuqiang Zhao, Peiran Zhao, Jing Yang. Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight. Metabolites 2024; 14(6) doi: 10.3390/metabo14060325
|
| 62 |
Ramón Cacabelos, Iván Tellado, Natalia Cacabelos, Olaia Martínez-Iglesias, Vinogran Naidoo. Pharmacoepigenetics. 2025; doi: 10.1016/B978-0-443-18722-3.00021-9
|
| 63 |
Rui Jiang, Hui Li, Jiameng Yang, Xuemei Shen, Chengchuang Song, Zhaoxin Yang, Xiaogang Wang, Yongzhen Huang, Xianyong Lan, Chuzhao Lei, Hong Chen. circRNA Profiling Reveals an Abundant circFUT10 that Promotes Adipocyte Proliferation and Inhibits Adipocyte Differentiation via Sponging let-7. Molecular Therapy Nucleic Acids 2020; 20 doi: 10.1016/j.omtn.2020.03.011
|
| 64 |
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis. Biomedicines 2021; 10(1) doi: 10.3390/biomedicines10010015
|
| 65 |
Archittapon Nokkeaw, Chaiyaboot Ariyachet. Advances in Circular RNAs. Advances in Experimental Medicine and Biology 2025; 1485 doi: 10.1007/978-981-96-9428-0_21
|
| 66 |
Tianrui Jing, Yifan Wu, Anran Wan, Chengmin Ge, Zi-Jiang Chen, Yanzhi Du. Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome. Biomolecules 2023; 13(7) doi: 10.3390/biom13071101
|
| 67 |
MENG HU, ZIYI FANG, YONGFU SHAO, JIANING YAN, GUOLIANG YE. Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies. Oncology Research 2025; 33(3) doi: 10.32604/or.2024.051589
|
| 68 |
Weihua Tian, Bo Zhang, Haian Zhong, Ruixue Nie, Yao Ling, Hao Zhang, Changxin Wu. Dynamic Expression and Regulatory Network of Circular RNA for Abdominal Preadipocytes Differentiation in Chicken (Gallus gallus). Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.761638
|
| 69 |
Xiaopeng Zhu, Mingfeng Xia, Xin Gao. Update on genetics and epigenetics in metabolic associated fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 2022; 13 doi: 10.1177/20420188221132138
|
| 70 |
Yong Li, Chao‐Qun Cen, Bo Liu, Lu Zhou, Xiang‐Miao Huang, Geng‐Yan Liu. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR‐200c/SIK2/PI3K/Akt axis. The Kaohsiung Journal of Medical Sciences 2022; 38(9) doi: 10.1002/kjm2.12568
|
| 71 |
Long-Fei Wu, Zhi-Jiang Zhou, Yu-Heng Zeng, Sheng-Li Yang, Qing-Ying Zhang. Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 327(4) doi: 10.1152/ajpgi.00255.2023
|
| 72 |
Chuangpeng Shen, Zhisen Pan, Wenmin Xie, Jian Zhao, Deyu Miao, Ling Zhao, Min Liu, Yanhua Zhong, Chong Zhong, Frank J. Gonzalez, Wei Wang, Yong Gao, Changhui Liu. Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation. Metabolism 2025; 162 doi: 10.1016/j.metabol.2024.156054
|
| 73 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24) doi: 10.3390/cells11243959
|
| 74 |
Mohamed Zaiou, Olivier Joubert. Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches. Biomolecules 2025; 15(5) doi: 10.3390/biom15050669
|
| 75 |
Yueh-Lin Wu, Hsiao-Fen Li, Hsi-Hsien Chen, Heng Lin. Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031032
|
| 76 |
Yan-Yu Peng, Dan Sun, Yan Xin. Hsa_circ_0005230 is up-regulated and promotes gastric cancer cell invasion and migration via regulating the miR-1299/RHOT1 axis. Bioengineered 2022; 13(3) doi: 10.1080/21655979.2022.2036514
|
| 77 |
Zhouxiao Li, Ye Cheng, Fan Wu, Liangliang Wu, Hongyong Cao, Qian Wang, Weiwei Tang. The emerging landscape of circular RNAs in immunity: breakthroughs and challenges. Biomarker Research 2020; 8(1) doi: 10.1186/s40364-020-00204-5
|
| 78 |
Huili Li, Thomas Herrmann, Jessica Seeßle, Gerhard Liebisch, Uta Merle, Wolfgang Stremmel, Walee Chamulitrat. Role of fatty acid transport protein 4 in metabolic tissues: insights into obesity and fatty liver disease. Bioscience Reports 2022; 42(6) doi: 10.1042/BSR20211854
|
| 79 |
Wujun Chen, Yihui Liu, Ling Li, Bing Liang, Shuai Wang, Xiaodan Xu, Dongming Xing, Xiaolin Wu. The potential role and mechanism of circRNAs in foam cell formation. Non-coding RNA Research 2023; 8(3) doi: 10.1016/j.ncrna.2023.03.005
|
| 80 |
Jun He, Ahmad Mahmoudi, Jacqueline Yao, Qiulin Yuan, Jinfeng Fu, Wei Liu. N6-methyladenosine methylation analysis of circRNAs in acquired middle ear cholesteatoma. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1396720
|
| 81 |
Meng Liang, Xiao Xiao, Miao Chen, Yi Guo, Weiting Han, Yahong Min, Xiaowen Jiang, Wenhui Yu. Artemisia capillaris Thunb. Water extract alleviates metabolic dysfunction-associated Steatotic liver disease Disease by inhibiting miR-34a-5p to activate Sirt1-mediated hepatic lipid metabolism. Journal of Ethnopharmacology 2025; 338 doi: 10.1016/j.jep.2024.119030
|
| 82 |
Jiayi Wang, Congcong Zhang, Yinghui Zhang, Jiaojiao Guo, Chenyu Xie, Yulu Liu, Lidian Chen, Liangliang Ma. Circular RNA in liver cancer research: biogenesis, functions, and roles. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1523061
|
| 83 |
Panpan Wang, Yunhuan Zhang, Lugang Deng, Zhi Qu, Peisen Guo, Limin Liu, Zengli Yu, Peixi Wang, Nan Liu. The function and regulation network mechanism of circRNA in liver diseases. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02559-1
|
| 84 |
Guocheng Rao, Xi Peng, Yan Tian, Xianghui Fu, Yuwei Zhang. Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1106665
|
| 85 |
Yongdong Peng, Anqi Liu, Qifei Zhu, Xiaotong Liu, Bingbing Cai, Zhiyu Yan, Jiwei Gao, Ruchang Zhu, Changfa Wang. Advances in the Regulation of Lipid Metabolism by Non-Coding RNAs. Animals 2025; 15(17) doi: 10.3390/ani15172621
|
| 86 |
Mohamed Zaiou. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2022; 28(35): 5111-5128 doi: 10.3748/wjg.v28.i35.5111
|
| 87 |
FengJuan Chen, YuFeng Xing, ZhiJie Chen, XiaoMan Chen, Jie Li, Si Gong, Fang Luo, QingXian Cai. Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01817-4
|
| 88 |
Meiyi Song, Lu Xia, Mengxue Sun, Changqing Yang, Fei Wang. Circular RNAs. Advances in Experimental Medicine and Biology 2018; 1087 doi: 10.1007/978-981-13-1426-1_20
|
| 89 |
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020 doi: 10.1155/2020/8822859
|
| 90 |
Xiaoniu Dai, Yusi Cheng, Cuifen Wang, Jie Huang, Jie Chao. Role of circular RNAs in visceral organ fibrosis. Food and Chemical Toxicology 2021; 150 doi: 10.1016/j.fct.2021.112074
|
| 91 |
Ramón Cacabelos, Iván Tellado, Pablo Cacabelos. Pharmacoepigenetics. 2019; doi: 10.1016/B978-0-12-813939-4.00001-2
|